Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Liabilities and Shareholders Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $246.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A to $246.7 million in Q4 2025 year-over-year; TTM through Oct 2025 was $916.7 million, a 1895.12% increase, with the full-year FY2025 number at $295.7 million, up 543.64% from a year prior.
  • Liabilities and Shareholders Equity was $246.7 million for Q4 2025 at Kestra Medical Technologies, down from $266.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $295.7 million in Q2 2025 to a low of $45.9 million in Q2 2024.